Module 13 agents affecting GI motility Flashcards
Antidiarrheal meds
bismuth subsalicylate (pepto)
loperamide
opium derivaties
bismuth subsalicylate MOA
coats lining of GI tract and soothes irritation, preventing stimulation of local reflexes that cause excessive GI activity and diarrhea
bismuth subsalicylate AE
black coating on tongue
busmuth subsalicylate CI
renal failure
loperamide MOA
mu opioid agonist
does not cross BBB
-> slows peristalsis, inc. time for absorption
loperamide AE
abd. pain
N/V
bloating
loperamide CI
less than 2 y/o: fetal paralytic ileus
fever
e.coli/salmonella infections
laxatives MOA
promote defecation
retain fluid in GI tract
- dec. H2O absorption (salts produce osmotic effect, draw H2O in)
- inc. intestinal motility (inc. peristalsis)
- soften stool (surface active agents)
add bulk to stool
Saline and osmotic laxatives meds
polycarbophyl methylcellulose psyllium methylcellulose calcium polycarbophil mg salts milk of mg mg hydroxide mg citrate Na phosphate (enema) lactulose glycerin sorbitol
saline and osmotic laxative MOA
inc. fecal bulk
inc. GI motility by inc. fluid in GI tract
stimulate stretch receptors
Stimulant Laxatives meds
Senna
bisacodyl
castor oil
mineral oil
stimulant laxative MOA
direct action on intestinal mucosa
stimulate myenteric plexus
alter H2O and electrolyte secretion
Senna admin
tablets, granules, syrup
onset: 6-10hours
bisacodyl admin
PO, suppository
onset: 15-60 minutes
castor oil admin
onset: 2-6 hours
avoid in pregnancy
mineral oil admin
Onset: 6-8 hours
mineral oil MOA
lines GI tract
prevents absorption of water and electrolytes
Saline and osmotic laxative use
retain H2O in intestinal lumen, inc. intra-luminal pressure -> cholecystokinin release
- empty bowel before surgery or colon procedures
- evacuates bowel in 3 hours
Surfactant/stool softeners MOA
detergent activity
facilitates water to soften stool
surfactant/stool softener meds
docosate sodium
docosate calcium
docosate use
prevention of post-op and opioid induced constipation
- often in combo with senna
Lanaclotide MOA
stimulates intestinal fluid secretion and transit
- long term risks unknown
lanaclotide use
IBS with constipation
lubiprostone MOA
locally acting Cl channel activator that enhances Cl-rich intestinal fluid secretion
lubiprostone use
IBS with constipation